Emeline Kuhner-Stout, founder of Élastique Athletics, wanted to create a product that was easy to wear and benefitted lymphatic health. Photo courtesy of Élastique Athletics

A few years ago, Emeline Kuhner-Stout, a French ex-pat, was figuring out life as a new mom in a new city. She found her new life in Houston to be sedentary and all consumed with taking care of her baby. Her only time for herself were her daily trips to the gym, and she wanted to make it worth her while.

"There were so many more things I wanted to do for myself, and I just didn't have the time," Kuhner-Stout tells InnovationMap. "It would be so much more efficient if there was a way to combine [elements] to make products that would perform for us."

She noticed at this time that people were starting to care about what they wear to the gym, and she was also looking into the causes of cellulite. Kuhner-Stout and her husband, Myron, who's a patent attorney, started doing some research and found that there weren't any products that existed at the confluence of activewear and skincare.

Élastique Athletics was born to fill that need.

Creating a solution

Photo courtesy of Élastique Athletics

After deciding to tackle cellulite, Kuhner-Stout started doing her homework. She learned that cellulite was caused by poor lymphatic drainage and subsequent water retention.

"We did some research, and found that the best way to improve the appearance of your skin and move those fluids — because the cause [of cellulite] is really about those fluids that get trapped under your skin and cause a lot more negative effects other than skin appearance," Kuhner-Stout says.

She learned that exercise is the best move for improving lymphatic drainage, and another option is to do it manually through massaging and with compression. After around five years of research and development, Kuhner-Stout was able to release her first product for Élastique Athletics — a pair of leggings that have MicroPerle™ micro-massage beads in the compression leggings to massage the skin when worn.

Making space

Photo via instagram.com/elastiqueathletics

The L'Original legging launched online while Kuhner-Stout was working out of WeWork's Jones Building office. She started to realize that customers wanted to try the new type of legging on before they made the $220 investment, and WeWork didn't exactly have the try-on experience Kuhner-Stout wanted for her customers.

She opened the Élastique Athletics store in River Oaks Shopping District late last year and now hopes to use the space to bring women together, and Kuhner-Stout has had health and wellness experts in the space for events and workshops.

"I really want to build Élastique as a true wellness brand, and I think it's very important for us to interact with professionals who focus their energy and time on making women feel great," Kuhner-Stout says.

The new space is also about allowing customers to stay involved with Élastique.

"We want to turn our customers into advocates, and to do that, we have to be more than a product or brand," she says.

Growing her company

Photo courtesy of Élastique Athletics

Kuhner-Stout, who has funded her work by bootstrapping and a family and friends round, hopes to raise a seed round in the near future to continue her growth.

"We feel like we have enough data from our customers to do it right," Kuhner-Stout says on raising a round.

Élastique Athletics is also almost ready to launch its next product — a sports bra that is also optimized with the MicroPerle™ micro-massage bead technology. She also hopes to get her products into more physical spaces.

"These next few months, we are focusing on partnering with high-end spas," Kuhner-Stout says, adding that she wants people to think of her leggings more of a skincare treatment than just activewear.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas lands top 10 spot in new future of tech study

report

Texas is among the top 10 states making the biggest investments in digital innovation, according to a new study.

The study, conducted by web-hosting company Hostinger, puts Texas in eighth place among the states when it comes to these key metrics:

  • Financial impact of the digital economy
  • Amount of venture capital and grants received by digital startups
  • Number of government-run tech hubs
  • Presence of top-rated business incubators

“To many, the Texas story is one of oil magnates and real estate tycoons. But in recent decades, the state has emerged as an innovation and high-tech hub,” according to a report from the Federal Reserve Bank of Dallas.

On a scale of 1 to 100, Texas received a score of 79. California nabbed the top spot with a score of 100. Appearing behind California and ahead of Texas in the ranking are:

  • No. 2: New York
  • No. 3: Washington
  • No. 4: Illinois
  • No. 5: Massachusetts
  • No. 6: Missouri
  • No. 7: Wisconsin

In terms of ranking factors, Texas benefited the most from landing at No. 2 among the states for its impact on the digital economy. The study pegged Texas’ digital economic impact at $141.7 billion, well below California’s impact of $492.8 billion.

Hostinger relied primarily on government data on 31 states to come up with the ranking. “The research provides a detailed ranking based on a composite score that reflects each state's overall investment and capacity for digital innovation,” the company says.

More than 30,000 businesses in Texas participate in the digital economy, according to the Computer & Communications Industry Association (CCIA). Those businesses employ more than 633,000 people and account for over six percent of the state’s GDP, a key measure of economic strength.

“As technology companies face increasing scrutiny through state and national legislation and litigation, it’s crucial to recognize the significant positive impacts of the digital economy that resonate across the United States,” says the CCIA.

TMC names 2025 cohort of cancer treatment innovators

ready to grow

Texas Medical Center Innovation has named more than 50 health care innovators to the fifth cohort of its Accelerator for Cancer Therapeutics (ACT).

The group specializes in immunotherapy, precision drug discovery, monoclonal antibodies, and diagnostic and therapeutic technologies, according to a statement from TMC.

During the nine-month ACT program, participants will enjoy access to a network of mentors, grant-writing support, chemistry resources, and the entrepreneur-in-residence program. The program is designed to equip participants with the ability to secure investments, develop partnerships, and advance the commercialization of cancer therapeutics in Texas.

“With over 35 million new cancer cases predicted by 2050, the urgency to develop safer, more effective, and personalized treatments cannot be overstated,” Tom Luby, chief innovation officer at Texas Medical Center, said in a news release.

Members of the new cohort are:

  • Alexandre Reuben, Kunal Rai, Dr. Cassian Yee, Dr. Wantong Yao, Dr. Haoqiang Ying, Xiling Shen, and Zhao Chen, all of the University of Texas MD Anderson Cancer Center
  • Dr. Andre Catic and Dr. Martin M. Matzuk, both of the Baylor College of Medicine
  • Cynthia Hu and Zhiqiang An, both of UTHealth Houston
  • Christopher Powala, Aaron Sato, and Mark de Souza, all of ARespo Biopharma
  • Daniel Romo, Dr. Susan Bates, and Ken Hull, all of Baylor University
  • Eugene Sa & Minseok Kim, both of CTCELLS
  • Gomika Udugamasooriya and Nathaniel Dawkins, both of the University of Houston
  • Dr. Hector Alila of Remunity Therapeutics
  • Iosif Gershteyn and Victor Goldmacher, both of ImmuVia
  • João Seixas, Pedro Cal, and Gonçalo Bernardes, all of TargTex
  • Ken Hsu and Yelena Wetherill, both of the University of Texas at Austin
  • Luis Martin and Dr. Alberto Ocaña, both of C-Therapeutics
  • Dr. Lynda Chin, Dr. Keith Flaherty, Dr. Padmanee Sharma, James Allison, and Ronan O’Hagan, all of Project Crest/Apricity Health
  • Michael Coleman and Shaker Reddy, both of Metaclipse Therapeutics
  • Robert Skiff and Norman Packard, both of 3582.ai
  • Rolf Brekken, Uttam Tambar, Ping Mu, Su Deng, Melanie Rodriguez, and Alexander Busse, all of UT Southwestern Medical Center
  • Ryan Swoboda and Maria Teresa Sabrina Bertilaccio, both of NAVAN Technologies
  • Shu-Hsia Chen and Ping-Ying Pan, both of Houston Methodist
  • Thomas Kim, Philipp Mews, and Eyal Gottlieb, all of ReEngage Therapeutics
The ACT launched in 2021 and has had 77 researchers and companies participate. The group has collectively secured more than $202 million in funding from the NIH, CPRIT and venture capital, according to TMC.